Carlsmed (CARL) Operating Expenses (2024 - 2026)

Carlsmed (CARL) has 3 years of Operating Expenses data on file, last reported at $21.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 62.49% year-over-year to $21.7 million; the trailing twelve-month figure through Mar 2026 stood at $77.0 million (up 58.58% YoY), and the FY2025 full-year result was $68.6 million, up 55.34% from the prior year.
• Operating Expenses for Q1 2026 stood at $21.7 million, up from $20.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $21.7 million in Q1 2026 and bottomed at $10.9 million in Q2 2024.
• The 3-year median for Operating Expenses is $14.4 million (2025), against an average of $15.7 million.
• Peak annual rise in Operating Expenses reached 78.53% in 2025, while the deepest fall reached 41.26% in 2025.
• A 3-year view of Operating Expenses shows it stood at $11.7 million in 2024, then jumped by 78.53% to $20.9 million in 2025, then gained by 3.7% to $21.7 million in 2026.
• The last three Operating Expenses figures came in at $21.7 million (Q1 2026), $20.9 million (Q4 2025), and $19.0 million (Q3 2025), per Business Quant data.

Peer Comparison